Living Heart Smart
Living Heart Smart
Podcast Description
Cardiologists Talking Heart Health:
Dr. Matt DeVane and Dr. Carolyn Lacey take a light-hearted approach to help everyone learn all things "heart health". We tap into our years of clinical practice to guide you through; heart healthy nutrition and exercise, life saving heart procedures, atrial fibrillation, cholesterol and hypertension, heart disease prevention strategies and all the latest heart healthy gadgets and state-of-the-art technology- we will cover it all.
We look forward to your feedback and ideas for future heart healthy topics!
Podcast Insights
Content Themes
The podcast centers on heart health, covering topics such as atrial fibrillation, cholesterol management, heart attack recovery, dietary choices, and preventive measures. Episodes dive into intricate subjects like the Mediterranean diet, the significance of cholesterol testing, and managing lifestyle factors related to heart disease prevention.
Cardiologists, Dr. Matt DeVane and Dr. Carolyn Lacey, want to help everyone learn about living a “Heart Smart” Lifestyle. We tap into our years of clinical practice to guide you through; heart healthy nutrition and exercise, life-saving heart procedures, atrial fibrillation, cholesterol and hypertension. We review heart disease prevention strategies and all the latest heart healthy gadgets and state-of-the-art technology aimed at keeping your heart happy and healthy.
Episode #28
In this episode of Living Heart Smart, Dr. Matt DeVane and Dr. Carolyn Lacey discuss the new cholesterol-lowering medication Inclisiran, its mechanism of action, and how it compares to traditional statins. They explore who might benefit from this medication, practical aspects of its administration, potential side effects, and the challenges of insurance coverage. The conversation emphasizes the importance of lowering LDL cholesterol for heart health and the evolving landscape of cardiovascular medications.
Takeaways
Inclisiran is a new medication that can replace daily statins.
It works by blocking the PCSK9 protein, enhancing LDL receptor function.
Patients with statin intolerance may benefit from Enclisarin.
The medication is administered twice a year, improving compliance.
Enclisarin can be used in conjunction with statins for better LDL control.
It has shown significant LDL reduction in clinical trials.
Side effects are minimal, primarily limited to injection site reactions.
Insurance coverage can be a barrier to accessing Enclisarin.
Lowering LDL cholesterol is crucial for reducing cardiovascular risk.
The future of cholesterol management may include more innovative therapies.
Chapters
00:00 Introduction to Inclisiran and Statins
02:15 Understanding Inclisiran Mechanism of Action
04:54 Comparing Inclisiran and Statins
07:33 Practical Applications and Patient Selection
10:18 Addressing Lipoprotein(a) and Inclisiran
12:53 Side Effects and Compliance Issues
15:28 Insurance and Cost Considerations
18:18 Conclusion and Future Directions
Disclaimer
This podcast’s information is provided for general reference and was obtained from publicly accessible sources. The Podcast Collaborative neither produces nor verifies the content, accuracy, or suitability of this podcast. Views and opinions belong solely to the podcast creators and guests.
For a complete disclaimer, please see our Full Disclaimer on the archive page. The Podcast Collaborative bears no responsibility for the podcast’s themes, language, or overall content. Listener discretion is advised. Read our Terms of Use and Privacy Policy for more details.